EAACI: A European Declaration on Immunotherapy. Designing the future of allergen specific immunotherapy. - sprookjes - yvandenbroek - TriplyDB

EAACI: A European Declaration on Immunotherapy. Designing the future of allergen specific immunotherapy.

EAACI: A European Declaration on Immunotherapy. Designing the future of allergen specific immunotherapy.

http://www.wikidata.org/entity/Q30394524

about

Allergic Rhinitis and Chronic Daily Headaches: Is There a Link?Therapeutic interventions in severe asthma Mite-Allergic Rhinitis: How to Evaluate Clinical Efficacy in Allergen-Specific Immunotherapy Trials?Sublingual immunotherapy: World Allergy Organization position paper 2013 update.A meta-analysis of sublingual allergen immunotherapy and pharmacotherapy in pollen-induced seasonal allergic rhinoconjunctivitis A prospective study comparing the efficacy and safety of two sublingual birch allergen preparations.Molecular biomarkers for grass pollen immunotherapy.Clinical contraindications to allergen immunotherapy: an EAACI position paper.The major birch pollen allergen Bet v 1 induces different responses in dendritic cells of birch pollen allergic and healthy individuals.Vitamin D and the development of allergic disease: how important is it?Allergen-Specific Immunotherapy with Monomeric Allergoid in a Mouse Model of Atopic Dermatitis.Research needs in allergy: an EAACI position paper, in collaboration with EFA.The Saudi Initiative for Asthma - 2016 update: Guidelines for the diagnosis and management of asthma in adults and children.The 11S globulin Sin a 2 from yellow mustard seeds shows IgE cross-reactivity with homologous counterparts from tree nuts and peanut Patient related outcomes in a real life prospective follow up study: Allergen immunotherapy increase quality of life and reduce sick days.Impact of allergic rhinitis and specific subcutaneous immunotherapy on peripheral blood basophils of patients sensitized to Dermatophagoides pteronyssinus.Respiratory allergies: a general overview of remedies, delivery systems, and the need to progress Safety and efficacy of tree pollen specific immunotherapy on the ultrarush administration schedule method using purethal trees Clinical practice recommendations for allergen-specific immunotherapy in children: the Italian consensus report Allergen-specific immunotherapy in asthmatic children: from the basis to clinical applications.Allergology in Europe, the blueprint.Prevention of anaphylaxis in healthcare settings.Balancing efficacy against safety in sublingual immunotherapy with inhalant allergens: what is the best approach?Venom immunotherapy: an updated review.New product development with the innovative biomolecular sublingual immunotherapy formulations for the management of allergic rhinitis.Current controversies and challenges in allergic rhinitis management.dIvergEnt: How IgE Axis Contributes to the Continuum of Allergic Asthma and Anti-IgE Therapies.Vaccines: could asthma in young children be a preventable disease? ‬‬‬‬‬‬‬.Immunotherapy in allergic rhinitis and lower airway outcomes.Proteomics for Allergy: from Proteins to the Patients.Novel approaches and perspectives in allergen immunotherapy.Escaping the trap of allergic rhinitis.Multivalent paediatric allergy vaccines protect against allergic anaphylaxis in mice.The effects of house dust mite sublingual immunotherapy in patients with allergic rhinitis according to duration.Allergen immunotherapy on the way to product-based evaluation-a WAO statement.Impact of early diagnosis and control of chronic respiratory diseases on active and healthy ageing. A debate at the European Union Parliament.Immunotherapy of house dust mite allergy.What is needed for allergic children?Chinese Guideline on allergen immunotherapy for allergic rhinitis.From genomes to diaries: a 3-year prospective, real-life study of ragweed-specific sublingual immunotherapy.

P2860

Q26768647-3E96F26D-4408-4497-921A-04374F7EAFB8 Q28079238-FABFFC74-1209-4271-A7E2-D934A95D59BD Q28082353-35CCAF86-CC2A-41FD-9A0C-534474272619 Q30440195-F4CF1C63-2CB9-4DB8-958F-D3387518A921 Q33914193-CF90E15A-86D7-4D19-A2CE-DCA3405E2049 Q34003337-029CAC57-BAE4-48E5-B535-964ACE887FB4 Q34093047-6FCFB646-A126-4795-A4D7-BB46F6A6D700 Q34669524-3A53B1E1-1691-4C22-9559-67080965D4A1 Q35031890-DD6E62F2-A0F1-4443-9971-139FC185389B Q35204523-8DA9538A-C961-4BC7-8D4D-1BC121DC3993 Q35746514-90E6FA14-4145-45C4-A22F-6F07EB529DB8 Q36517533-33007FB0-0AE3-4900-9D6B-B658659B3A1F Q36566081-F64DAF0F-9AFD-4DB6-95B1-D383B288A990 Q36640935-5FFEEF9B-B6D9-4614-95DD-90C072086ED1 Q37355463-DD13FCAE-5087-4D22-BC35-967566CBCF77 Q37367532-3859E697-5D8B-49E2-81DD-D394FD593E8C Q37679681-2019ED1B-7644-48B3-88DE-27367A104BF3 Q37695638-1CDB3EE7-ECB7-45D1-986D-C1285638A9E8 Q37696401-34A50F4B-907A-4A9D-9966-7BABE5280D01 Q38113269-08E5F987-FD8B-4D93-B73E-600577BA8082 Q38140060-94731D47-1FCF-4254-8062-25DB281C3887 Q38144110-81E2161C-1D20-48C1-A660-F43C073C05F2 Q38149941-A0F177D0-F666-4075-A90A-E446F02BFBD7 Q38220704-36500497-5E5D-459F-8149-20832F8F257C Q38253352-36A7AEC3-8997-4569-B9D9-5B4C5B1DFA2B Q38577949-CE4A0C4B-B9B8-4CB9-A8D1-8431C6772303 Q38715930-7ED816A1-386F-403A-B113-27F0E7F475B3 Q38832835-A88EFDBF-37B4-49B1-91B3-CBBD934AA653 Q38903486-62556B1C-CA12-481D-B892-6F61D832B1FA Q38930142-EF63BAAC-326C-4968-BF10-9D1767374197 Q39103046-628959D5-A1A5-4AF4-8A6B-1B4468960C5C Q39185309-F3BA677C-B0D7-4741-8747-35CE7E3C6A33 Q39305632-1464E09E-1CEA-444A-9F02-C2EE8FA86520 Q40314112-37F31715-08E3-4BE8-A730-F0FFD2EAA89E Q43249691-497A146C-FC02-4549-A282-022347C0EEF2 Q43476026-22EEA08E-5511-4F0A-A3C3-4312507E163A Q43915564-74B87E9B-99C1-4AEF-B68E-8E0FD6E366BC Q46924864-EDF3085A-8E30-4202-9A96-F617B9F84F1D Q47149942-1EA2A167-C279-4573-96F8-33AF2FBAE9BB Q47609326-73C19E73-26FE-4994-908B-1E3400D1A6A9

P2860

EAACI: A European Declaration on Immunotherapy. Designing the future of allergen specific immunotherapy.

http://www.wikidata.org/entity/Q30394524

description

2012 nî lūn-bûn

@nan

2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

EAACI: A European Declaration ...... lergen specific immunotherapy.

@ast

EAACI: A European Declaration ...... lergen specific immunotherapy.

@en

type

label

EAACI: A European Declaration ...... lergen specific immunotherapy.

@ast

EAACI: A European Declaration ...... lergen specific immunotherapy.

@en

prefLabel

EAACI: A European Declaration ...... lergen specific immunotherapy.

@ast

EAACI: A European Declaration ...... lergen specific immunotherapy.

@en

P1433

Q30394524-62403095-4255-477A-91A2-31E2650AAC8C

P1476

Q30394524-40E167C0-C5A6-420C-8301-878692CE5D15

P2093

Q30394524-0188E1B4-BBD3-40C6-8121-58C238700A19

Q30394524-027C40B4-909D-4361-A944-B4AF7F360904

Q30394524-0819FFA3-6C7A-44EC-AAEF-E17BABD48ED1

Q30394524-09683932-5776-43FB-BFFF-33EF84A36D2B

Q30394524-1EB4192B-427D-4156-8081-81F968A99B3A

Q30394524-1F81034E-B3A9-4772-BCBB-FADBCDE32E9D

Q30394524-3A3D3103-F0A6-4D28-B516-45203A013F7F

Q30394524-4459447A-CD94-4256-9B53-2C5FD884E8A1

Q30394524-4FC5724A-B1D6-4BDD-B7D2-06F754AEC164

Q30394524-50425F24-D3E1-4712-BB3F-A34950BD3BEF

P2860

Q30394524-036C33AE-CE91-4AA8-924A-7403F15B600D

Q30394524-055E14FB-7E07-4736-945D-A45AD013C572

Q30394524-070594A4-257E-4CD1-962E-ED0485C01CFF

Q30394524-0B810664-4578-4FA4-955D-40520E76526A

Q30394524-0C0224B4-22FA-4A44-92FE-2EBA433F3B9C

Q30394524-0DEF6DCC-A4F7-4653-A355-09BACFCC1A61

Q30394524-1824BE77-0C9C-4AC9-8A0F-B880D47EEE45

Q30394524-194F3465-9EB7-4197-8776-BDD5269A1386

Q30394524-21225AC3-92BB-40DC-BF86-9E69B71428CA

Q30394524-254D3649-F232-4B03-A896-C21789401622

P2888

Q30394524-8F5D31D3-2C7D-4289-AD03-255A635F3E7D

P304

Q30394524-589E7211-B33D-45DA-A897-69EFCCE1E840

P31

Q30394524-997ECAEE-0586-4D1C-B5F3-B7A6E7928C02

P356

Q30394524-81EAF317-5EFA-41EE-A2FA-484739CF707C

P433

Q30394524-A77FC4B2-AF9B-4D0B-AB76-466345F4A2D6

P478

Q30394524-67FC3B5D-8575-4E80-A7BD-FBF0F4EA1C19

P50

Q30394524-566C53E0-660C-4946-B871-DA0E1318EDD6

Q30394524-59A425B3-18FB-40C6-8958-BA511A7CCE7A

Q30394524-6D41294F-88B1-4772-82B3-E3D9A8E78D21

Q30394524-C452528C-0E3D-4693-82EC-6AFBB50B61EA

Q30394524-DC4A6A26-A285-4F4A-A6BA-32E75B5BB897

Q30394524-E672CF2A-1C92-43AC-88EA-C0CA16ACA4ED

Q30394524-E818C645-8C3F-418D-B166-D062367BCA51

Q30394524-E89A7162-B70A-4DC6-AAE1-16BE1863ED86

Q30394524-EAF39E30-39D1-4419-89E9-DE16CCC32FAD

P577

Q30394524-11D9B7B0-ED39-4119-8CDA-BDF13BB34365

P5875

Q30394524-846F684E-1A67-4CB9-8821-9B9B4ECD863C

P6179

Q30394524-0DA539E9-AC54-4F0F-B50B-F1A8FFAB997A

P698

Q30394524-E34ED38E-7B3F-42E7-B582-42CEACDBB0FC

P921

Q30394524-8E92B41B-60D1-4396-8389-A29C36B2DCBB

P932

Q30394524-EEF65A5F-C296-428F-A768-56043ED4380A

P356

P1433

Clinical and translational allergy

P1476

EAACI: A European Declaration ...... lergen specific immunotherapy.

@en

P2093

Alain Didier

http://www.w3.org/2001/XMLSchema#string

Anthony Frew

http://www.w3.org/2001/XMLSchema#string

Antonella Muraro

http://www.w3.org/2001/XMLSchema#string

Antonio Nieto

http://www.w3.org/2001/XMLSchema#string

Barbara Bohle

http://www.w3.org/2001/XMLSchema#string

Beatrice Bilo

http://www.w3.org/2001/XMLSchema#string

Bodo Niggemann

http://www.w3.org/2001/XMLSchema#string

Carmen Moreno

http://www.w3.org/2001/XMLSchema#string

Carmen Vidal

http://www.w3.org/2001/XMLSchema#string

Emilio Alvarez-Cuesta

http://www.w3.org/2001/XMLSchema#string

P2860

Injection allergen immunotherapy for asthma

Allergen injection immunotherapy for seasonal allergic rhinitis

Sublingual immunotherapy for allergic rhinitis

The diagnosis and management of rhinitis: an updated practice parameter

Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys

Worldwide trends in the prevalence of asthma symptoms: phase III of the International Study of Asthma and Allergies in Childhood (ISAAC)

ARIA update: I--Systematic review of complementary and alternative medicine for rhinitis and asthma.

Establishing the incidence and prevalence of clinician-diagnosed allergic conditions in children and adolescents using routinely collected data from general practices.

Long-term clinical efficacy of grass-pollen immunotherapy.

Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study.

P2888

P304

20

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/2045-7022-2-20

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P50

Victoria Cardona

Gianenrico Senna

Giovanni Passalacqua

P577

2012-10-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

232740772

http://www.w3.org/2001/XMLSchema#string

P6179

1038911112

http://www.w3.org/2001/XMLSchema#string

P698

23110958

http://www.w3.org/2001/XMLSchema#string

P921

P932

3514324

http://www.w3.org/2001/XMLSchema#string